Insider Transactions in Q3 2022 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
230
+10.69%
|
-
|
|
Sep 30
2022
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
230
+0.01%
|
-
|
|
Sep 30
2022
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
230
+0.31%
|
-
|
|
Sep 30
2022
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
346
+0.91%
|
-
|
|
Sep 30
2022
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
533
+50.0%
|
-
|
|
Sep 30
2022
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
374
+9.93%
|
-
|
|
Sep 29
2022
|
Michael D Loberg Director |
BUY
Open market or private purchase
|
Indirect |
5,821
+14.15%
|
$110,599
$19.62 P/Share
|
|
Sep 28
2022
|
Michael D Loberg Director |
BUY
Open market or private purchase
|
Indirect |
6,172
+17.31%
|
$123,440
$20.97 P/Share
|
|
Sep 27
2022
|
Michael D Loberg Director |
BUY
Open market or private purchase
|
Indirect |
507
+2.13%
|
$9,633
$19.99 P/Share
|
|
Sep 08
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-10.58%
|
$190,000
$19.96 P/Share
|
|
Sep 08
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.81%
|
$0
$0.93 P/Share
|
|
Sep 07
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-20.21%
|
$190,000
$19.04 P/Share
|
|
Sep 07
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.81%
|
$0
$0.93 P/Share
|
|
Sep 06
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-11.24%
|
$95,000
$19.06 P/Share
|
|
Sep 06
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.1%
|
$0
$0.93 P/Share
|
|
Aug 22
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
6,300
-13.76%
|
$126,000
$20.71 P/Share
|
|
Aug 22
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+12.09%
|
$0
$0.93 P/Share
|
|
Aug 19
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
8,700
-18.05%
|
$191,400
$22.82 P/Share
|
|
Aug 19
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,700
+15.29%
|
$0
$0.93 P/Share
|
|
Aug 18
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-20.21%
|
$220,000
$22.54 P/Share
|
|
Aug 18
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.81%
|
$0
$0.93 P/Share
|
|
Jul 18
2022
|
Michael D Loberg Director |
BUY
Bona fide gift
|
Indirect |
533
+2.28%
|
-
|
|
Jul 18
2022
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
533
-100.0%
|
-
|